RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Replimune Group - Stock

Replimune Group P/S 2024

Replimune Group P/S

0

Ticker

REPL

ISIN

US76029N1063

WKN

A2JQN1

As of Jul 5, 2024, Replimune Group's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.

The Replimune Group P/S history

Replimune Group Aktienanalyse

What does Replimune Group do?

Replimune Group Inc is an American biotechnology company based in Woburn, Massachusetts. The company focuses on the development of therapeutics for cancer treatments through the application of oncolytic viruses. Replimune Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Replimune Group's P/S Ratio

Replimune Group's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Replimune Group's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Replimune Group's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Replimune Group’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Replimune Group stock

What is the price-to-earnings ratio of Replimune Group?

The price-earnings ratio of Replimune Group is currently 0.

How has the price-earnings ratio of Replimune Group changed compared to last year?

The price-to-earnings ratio of Replimune Group has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Replimune Group high compared to other companies?

Yes, the price-to-earnings ratio of Replimune Group is high compared to other companies.

How does an increase in the price-earnings ratio of Replimune Group affect the company?

An increase in the price-earnings ratio of Replimune Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Replimune Group affect the company?

A decrease in the price-earnings ratio of Replimune Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Replimune Group?

Some factors that influence the price-earnings ratio of Replimune Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Replimune Group pay?

Over the past 12 months, Replimune Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Replimune Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Replimune Group?

The current dividend yield of Replimune Group is .

When does Replimune Group pay dividends?

Replimune Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Replimune Group?

Replimune Group paid dividends every year for the past 0 years.

What is the dividend of Replimune Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Replimune Group located?

Replimune Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Replimune Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Replimune Group from 7/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/5/2024.

When did Replimune Group pay the last dividend?

The last dividend was paid out on 7/5/2024.

What was the dividend of Replimune Group in the year 2023?

In the year 2023, Replimune Group distributed 0 USD as dividends.

In which currency does Replimune Group pay out the dividend?

The dividends of Replimune Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Replimune Group

Our stock analysis for Replimune Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Replimune Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.